Yuri Lazebnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuri Lazebnik has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Joe Rodriguez
Cold Spring Harbor Laboratory 1 Bungtown Road Cold Spring Harbor, NY 11724, USA
3 shared publicationsEve-Ellen Govek
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724
1 shared publicationGreg Hannon
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724
1 shared publication- Howard Oliver Fearnhead
Pharmacology and Therapeutics, School of Pharmacy and Medical Sciences, College of Medicine Nursing and Health Sciences University of Galway Ireland
1 shared publication Hsu-Hsin Chen
Cold Spring Harbor Laboratory 1 Bungtown Road Cold Spring Harbor, NY 11724, USA
1 shared publicationLavina Faleiro
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724, USA
1 shared publication
Latest Publications
- 1 December 2004
- Published by Springer Nature in Biochemistry (Moscow)
- Vol. 69 (12) , 1403-1406
Can a biologist fix a radio? — or, what i learned while studying apoptosis
- 1 December 2004
- Published by Springer Nature in Biochemistry (Moscow)
- Vol. 69 (12) , 1403-1406
Can a biologist fix a radio? — or, what i learned while studying apoptosis
- 1 December 2004
- Published by Springer Nature in Biochemistry (Moscow)
- Vol. 69 (12) , 1403-1406
Can a biologist fix a radio? — or, what I learned while studying apoptosis
- 1 December 2004
- Published by Springer Nature in Biochemistry (Moscow)
- Vol. 69 (12) , 1403-1406
Can a biologist fix a radio? — or, what I learned while studying apoptosis
- Open Access
- 27 November 2000
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 151 (5) , 951-960
Caspases Disrupt the Nuclear-Cytoplasmic Barrier
During apoptosis, caspases, a family of proteases, disassemble a cell by cleaving a set of proteins. Caspase-3 plays a major role in the disassembly of the nucleus by processing several nuclear substrates. The question is how caspase-3, which is usually cytoplasmic, gains access to its nuclear targets. It was suggested that caspase-3 is actively transported to the nucleus through the nuclear pores. We found that caspase-9, which is activated earlier than caspase-3, directly or indirectly inactivates nuclear transport and increases the diffusion limit of the nuclear pores. This increase allows caspase-3 and other molecules that could not pass through the nuclear pores in living cells to enter or leave the nucleus during apoptosis by diffusion. Hence, caspase-9 contributes to cell disassembly by disrupting the nuclear-cytoplasmic barrier.
- 27 November 2000
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 151 (5) , 951-960
Open AccessCaspases Disrupt the Nuclear-Cytoplasmic Barrier
During apoptosis, caspases, a family of proteases, disassemble a cell by cleaving a set of proteins. Caspase-3 plays a major role in the disassembly of the nucleus by processing several nuclear substrates. The question is how caspase-3, which is usually cytoplasmic, gains access to its nuclear targets. It was suggested that caspase-3 is actively transported to the nucleus through the nuclear pores. We found that caspase-9, which is activated earlier than caspase-3, directly or indirectly inactivates nuclear transport and increases the diffusion limit of the nuclear pores. This increase allows caspase-3 and other molecules that could not pass through the nuclear pores in living cells to enter or leave the nucleus during apoptosis by diffusion. Hence, caspase-9 contributes to cell disassembly by disrupting the nuclear-cytoplasmic barrier.
- 25 February 2000
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 287 (5457) , 1363
Caspase Phosphorylation, Cell Death, and Species Variability
- 25 February 2000
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 287 (5457) , 1363
Caspase Phosphorylation, Cell Death, and Species Variability
- Open Access
- 15 December 1999
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 13 (24) , 3179-3184
Caspase-9 and APAF-1 form an active holoenzyme
Autocatalytic activation of initiator caspases is the link between pro-apoptotic signals and the destruction machinery of apoptosis. Activation of caspase-9, which mediates oncogene and drug-induced apoptosis, requires binding to the protein APAF-1. We found that the proteolytic activity of caspase-9 in a complex with APAF-1 is several orders of magnitude higher than that of the free enzyme. Thus, this complex functions as a holoenzyme in which caspase-9 is the catalytic subunit and APAF-1 its allosteric regulator. We argue that caspase-9 is activated by allosteric regulation and suggest that this mechanism is common for other initiator caspases.
- 15 December 1999
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 13 (24) , 3179-3184
Open AccessCaspase-9 and APAF-1 form an active holoenzyme
Autocatalytic activation of initiator caspases is the link between pro-apoptotic signals and the destruction machinery of apoptosis. Activation of caspase-9, which mediates oncogene and drug-induced apoptosis, requires binding to the protein APAF-1. We found that the proteolytic activity of caspase-9 in a complex with APAF-1 is several orders of magnitude higher than that of the free enzyme. Thus, this complex functions as a holoenzyme in which caspase-9 is the catalytic subunit and APAF-1 its allosteric regulator. We argue that caspase-9 is activated by allosteric regulation and suggest that this mechanism is common for other initiator caspases.
- 10 November 1998
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (23) , 13664-13669
Oncogene-dependent apoptosis is mediated by caspase-9
Understanding how oncogenic transformation sensitizes cells to apoptosis may provide a strategy to kill tumor cells selectively. We previously developed a cell-free system that recapitulates oncogene dependent apoptosis as reflected by activation of caspases, the core of the apoptotic machinery. Here, we show that this activation requires a previously identified apoptosis-promoting complex consisting of caspase-9, APAF-1, and cytochrome c . As predicted by the in vitro system, preventing caspase-9 activation blocked drug-induced apoptosis in cells sensitized by E1A, an adenoviral oncogene. Oncogenes, such as E1A, appear to facilitate caspase-9 activation by several mechanisms, including the control of cytochrome c release from the mitochondria.
- 10 November 1998
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (23) , 13664-13669
Oncogene-dependent apoptosis is mediated by caspase-9
Understanding how oncogenic transformation sensitizes cells to apoptosis may provide a strategy to kill tumor cells selectively. We previously developed a cell-free system that recapitulates oncogene dependent apoptosis as reflected by activation of caspases, the core of the apoptotic machinery. Here, we show that this activation requires a previously identified apoptosis-promoting complex consisting of caspase-9, APAF-1, and cytochrome c . As predicted by the in vitro system, preventing caspase-9 activation blocked drug-induced apoptosis in cells sensitized by E1A, an adenoviral oncogene. Oncogenes, such as E1A, appear to facilitate caspase-9 activation by several mechanisms, including the control of cytochrome c release from the mitochondria.